Intrapartum Azithromycin and Neonatal and Maternal Outcomes, Olamkicept for Ulcerative Colitis, FDA Mandate Limiting Acetaminophen in Combination Opioid Products and Liver Failure, and more

Release Date:

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, The Journal of the American Medical Association, for the March 7, 2023, issue.

Intrapartum Azithromycin and Neonatal and Maternal Outcomes, Olamkicept for Ulcerative Colitis, FDA Mandate Limiting Acetaminophen in Combination Opioid Products and Liver Failure, and more

Title
Intrapartum Azithromycin and Neonatal and Maternal Outcomes, Olamkicept for Ulcerative Colitis, FDA Mandate Limiting Acetaminophen in Combination Opioid Products and Liver Failure, and more
Copyright
Release Date

flashback